Strategies for reducing the exposure to donor blood.
Murphy
Mike
M
National Blood Service, Department of Haematology, Oxford Radcliffe Hospitals, University of Oxford. mike.murphy@nbs.nhs.uk
D001424:Bacterial Infections / Q000635:transmission; D001782:Blood Donors; D001803:Blood Transfusion / Q000592:standards*; D004921:Erythropoietin / Q000627:therapeutic use; D005169:Factor VIII / Q000627:therapeutic use; D006470:Hemorrhage / Q000517:prevention & control*; D006801:Humans; D019990:Perioperative Care; D011786:Quality Control; D011994:Recombinant Proteins; D012449:Safety; D065227:Transfusion Reaction; D014777:Virus Diseases / Q000635:transmission
D011994:Recombinant Proteins; D004921:Erythropoietin; C078147:F8 protein, human; D005169:Factor VIII